Promoting Donor Care

The global independent, professionally-led biovigilance scheme

WMDA is operating the global independent, professionally-led biovigilance scheme. Since 2003 WMDA has been collecting and analysing anonymised information on adverse events and reactions in stem cell donation and transfusion from all member organisations that are involved in the provision of cells for unrelated patients.  Where risks and problems are identified, WMDA produces recommendations to improve donor and patient safety.  The recommendations are put into its annual report which is then circulated to all relevant professional bodies as well as circulating it to all of the reporting WMDA member organisations.  As biovigilance is an ongoing exercise, WMDA can also monitor the effect of the implementation of its recommendations and ensure donor care through its accreditation programme.

The Donor Care Pillar of WMDA is operating the biovigilance programme and ensures that recommendations are in place to protect the donor for all type of donatioins till years after donation.

Webshoprelated items